期刊文献+

A Dynamic Covalent Bonding-based Nanoplatform for Intracellular Co-Delivery of Protein Drugs and Chemotherapeutics with Enhanced Anti-Cancer Effect 被引量:1

原文传递
导出
摘要 Efficient intracellular delivery of protein drugs is critical for protein therapy.The combination of protein drugs with chemotherapeutics represents a promising strategy in enhancing anti-cancer effect.However,co-delivery systems for efficient delivery of these two kinds of drugs are still lacking because of their different properties.Herein,we show a well-designed delivery system based on dynamic covalent bond for efficient intracellular co-delivery of ribonuclease A(RNase A)and doxorubicin(DOX).Two polymers,PEG-b-P(Asp-co-AspDA)and PAE-b-P(Asp-co-AspPBA),and two 2-acetylphenylboronic acid(2-APBA)-functionalized drugs,2-APBA-RNase A and 2-APBA-DOX,self-assemble into mixed-shell nanoparticles(RNase A/DOX@MNPs)via dynamic phenylboronic acid(PBA)-catechol bond between PBA and dopamine(DA)moieties.The PBA-catechol bond endows the nanoparticles with high stability and excellent stimulus-responsive drug release behavior.Under the slight acidic environment at tumor tissue,RNase A/DOX@MNPs are positively charged,promoting their endocytosis.Upon cellular uptake into endosome,further protonation of PAE chains leads to the rupture of endosomes because of the proton sponge effect and the cleavage of PBA-catechol bond promotes the release of two drugs.In cytoplasm,the high level of GSH removed the modification of 2-APBA on drugs.The restored RNase A and DOX show a synergistic and enhanced antic-cancer effect.This system may be a promising platform for intracellular co-delivery of protein drugs and chemotherapeutics.
出处 《Chinese Journal of Polymer Science》 SCIE EI CAS CSCD 2024年第5期559-569,I0005,共12页 高分子科学(英文版)
基金 This work was financially supported by the National Key R&D Program of China(Nos.2022YFA1205703 and 2022YFA1205702) the National Natural Science Foundation of China(Nos.51773099,51933006 and 52103183) Haihe Laboratory of Sustainable Chemical Transformations(No.YYJC202102).
  • 相关文献

参考文献5

二级参考文献34

  • 1Mizuno,N.,Niwa,T.,Yotsumoto,Y.and Sugiyama,Y.,Pharm.Rev.,2003,55:425. 被引量:1
  • 2Putnam,A.J.and Mooney,D.J.,Nat.Med.,1996,2:824. 被引量:1
  • 3Zeng,Y.F.,Tseng,S.J.,Kempson,I.M.,Peng,S.F.,Wu,W.T.and Liu,J.R.,Biomaterials,2012,33(36):9239. 被引量:1
  • 4Casolaro,M.,Cini,R.,Bello,B.D.,Ferrali,M.and Maellaro,E.,Biomacromolecules,2009,10:944. 被引量:1
  • 5Casolaro,M.,Bottari,S.and Ito,Y.,Biomacromolecules,2006,7:1439. 被引量:1
  • 6Hu,Y.F.,Liu,Y.F.,Qi,X.,Liu,P.,Fan,Z.Y.and Li,S.M.,Polym.Int.,2012,61(1):74. 被引量:1
  • 7Cai,M.T.,Zhang,J.X.,Chen,Y.W.,Cao,J.and Leng,M.T.,Chinese J.Polym.Sci.,2014,32(2):236. 被引量:1
  • 8Harada,T.,Misaki,A.and Saito,H.,Arch.Biochem.Biophys.,1968,124:292. 被引量:1
  • 9Mclntosh,M.,Stone,B.A.and Stanisich,V.A.,Appl.Microbiol.Biotechnol.,2005,68:163. 被引量:1
  • 10Funami,T.,Funami,M.,Yada,H.and Nakao,Y.,Food Hydrocolloid.,2000,14(5):509. 被引量:1

共引文献6

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部